NerPharMa, a CDMO with a strong specialization in Oncology on NCEs, innovative formulations and new technologies. Two different departments: NerPharMa DP dealing with the development and manufacturing of compounds, injectables and solid oral for various therapeutic areas, packaging, distribution and regulatory support; NerPharMa DS dealing with the development and production of oncological active principles from laboratory scale to commercial products.